Midwest AViDD Center

A discovery by the @MidwestAViDD Center published in @NaturePortfolio shows that Marburg is 300 times more efficient at entering human cells than Ebola. The research also establishes a therapeutic path to combat infection. nature.com/articles/s4158…

🔬 Dr. Fang Li studies how viruses break into human cells—and how to stop them. His early research helped shape the global #COVID19 response, and his work continues to guide efforts against some of the world’s most dangerous viruses. Read his story at: bit.ly/3ONFKEe.

A new paper published in @PLOSPathogens by the @MidwestAViDD Project 5 Helicase team shows that a novel anti-Zika compound has superior potency, and its target, #NS4B, could hold the key to pan-flavivirus therapeutic development. #zika #flavivirus journals.plos.org/plospathogens/…

Link to Nature paper: nature.com/articles/s4158…

Dr. Fang Li was interviewed by @ICT_magazine about his lab's @NaturePortfolio study, which shows how efficiently the Marburg virus enters human cells and what that means for outbreak preparedness. @FangLiLabUMN infectioncontroltoday.com/view/marburg-v…

For updates on the development of #nanobody therapeutics, #infectiousdisease research, and #structuralbiology discoveries related to some of the world's most challenging and deadly viruses, follow @FangLiLabUMN on Twitter! x.com/FangLiLabUMN?s…

Coverage of Midwest AViDD's Co-Director Fang Li's @NaturePortfolio paper in the @StarTribune! @FangLiLabUMN @umnmedschool #marburg #drugdiscovery #globalhealth #nanobodies startribune.com/u-of-m-researc…

Excited to share that our study on the Marburg virus is now published in Nature. Congratulations to the entire team and collaborators who made this work possible. nature.com/articles/s4158… med.umn.edu/news/universit… @MidwestAViDD @MPaT_PHCL_UMN @umnmedschool @UMNews

Congratulations to Midwest AViDD Co-Director Dr. Fang Li for receiving five awards, including the Dean's Distinguished Research Lectureship, the highest honor for Medical School faculty. View Dr. Li's presentation from the award ceremony here: youtube.com/watch?v=Ct_qJb…

Attend the Midwest AViDD Center's hybrid lecture series! Title: "Targeting Coronaviral Proteases with Direct Acting Antivirals" 🗓️ Monday, Nov. 25 @ 3 p.m. 🎙️ Speaker: Joanne Lemieux, PhD 📍 CCRB 1-125 or Zoom Zoom link: bit.ly/3CE8V6n. #UMN | @MidwestAViDD

Attend the Midwest AViDD Center's next hybrid lecture! Title: "From HIV-1 Reverse Transcriptase to LINE-1 and SARS-CoV-2: Targeting Polymerases in Various Diseases" 🗓️ Feb. 26 at 3 p.m. 🎙️ Speaker: Matthias Götte, PhD Zoom link: bit.ly/3ONUMqd. #UMN | @MidwestAViDD

Midwest Hybrid Lecture Series Featuring Matthias Gotte on Monday, February 26. umn.zoom.us/j/99869813701?… #universityofalberta

Welcome to Lauren Rault, a @UMN_MedChem graduate student, to the #HarkiLab! Lauren will be joining our program to develop orally bioavailable small molecule antiviral agents as part of the @MidwestAViDD. Welcome Lauren!

This is one way that SARS-CoV-2 has evolved to evade the immune system. The RBDs on the spike protein can open and close, but what triggers it? @umnmedschool @eLife midwestavidd.umn.edu/new-study-high…

Four researchers from the Midwest Antiviral Drug Discovery Center have been recognized as the most cited scientists globally @umnmedschool midwestavidd.umn.edu/four-researche…

Midwest AViDD Researcher Dr. Liang selected as first VBS Endowed Professor in Animal Health and Disease profiles-vetmed.umn.edu/article/liang-… @umnCVM

Midwest AViDD Center Antiviral Drug Discovery Work Highlighted at Minnesota Workshop midwestavidd.umn.edu/midwest-avidd-… @umnmedschool

Attend the Midwest AViDD Center's hybrid lecture series! "Metal-binding Chemotypes for Targeting RNase H-like Viral Enzymes" 🗓️ Sept. 25 at 3 p.m. Speaker: Zhengqiang (ZQ) Wang, Ph.D. Zoom link: bit.ly/46f0XKa #UMN @MidwestAViDD

Crucial Pandemic Research Wins Midwest AViDD Co-Director, Dr. Fang Li, Prestigious American Society of Microbiology Award midwestavidd.umn.edu/crucial-pandem… @ASMicrobiology @umnmedschool